Here’s a bit of hope for you, scientists have figured out how to trick the body into producing any protein or antibody they want, through technology like gene therapy and mRNA vaccines. We’re about to cure a lot of diseases that used to be 100% fatal. Diseases that kill kids and adults alike.
Most things seem to be getting worse these days, but at least we’re making progress in other areas.
For those interested in more, I found this People Make Games video to be super interesting. https://youtu.be/lYaDXZ2MI-k?si=pxrioKZq_S7ka9il
In grad school I worked with MRI data (hence the username). I had to upload ~500GB to our supercomputing cluster. Somewhere around 100,000 MRI images, and wrote 20 or so different machine learning algorithms to process them. All said and done, I ended up with about 2.5TB on the supercomputer. About 500MB ended up being useful and made it into my thesis.
Don’t stay in school, kids.
The duality of humanity right here. I hated academics and I’m way happier facing clients. Because even if they’re being unreasonable, they’re still paying me more than a living wage which is more than I could say about my advisor
Can’t say I’ve heard anything since launch, so take my advice with a grain of salt.
Grim Dawn Item Assistant is your best friend. While you’re at it, Rainbow Item Names (or whatever it’s called).
Well if you liked PoE I doubt you’ll like D4. It’s a much simpler game. Sadly my only advice is to try GD and Last Epoch again. I’ve got hundreds of hours in the former and I just got 10 hours into the latter.
Last Epoch feels like a more approachable PoE. I thoroughly enjoy how the skills interplay with one another, but I still prefer the itemization in Grim Dawn.
The only reason I’m not playing GD currently is because I have too many QoL mods installed so my cloud saving doesn’t work, but I can cloud save for Last Epoch for my steam deck lmao.
The software is a little finicky and likes to show you whatever profile is active when you switch to it. So if you don’t like a key bind for Cov 6 and you tab over to the software, it switches back to your default profile.
And, if the game isn’t officially supported, you’ll have to manually locate the files. Usually not an issue but it was a pain for Minecraft.
Pretty minor grievances though, the software works 99% of the time.
Logitech G502 has been going strong for 3 years, and I love it so much. The software is easy enough, and I can’t live without profile switching. I have two I use for daily driving - one with Ctrl, Page up, Page down, Forward, and Back on browser - and profile 2 has Win+Tab, Alt+Tab, and Navigate through Alt+Tab bound. Biggest downside is updating game profiles is a bit of a pain.
Ooh, I know this one. It comes from old English, meaning “small thing”
I have to ask - was Guandong a warzone? I’m all for pointing out how awful things are, and that’s a lot of money for a rickety pier, but I do want to make sure we’re comparing apples to apples.
10/10 no notes
I won’t tolerate slander against JYOCHO, they’re one of my favorite bands. The guitarist, Daijiro, played with another small group, Uchu Conbini. They finally put their music on Spotify so I can continue to listen. https://youtu.be/XWqua6rsEmw?si=I5cJwe3kNJNzXHzw
Maybe this is more your speed? https://youtu.be/lSJrSxGfMgY?si=IlglJT_KRJczVnrp
Unfortunately there’s a lot of truth in that statement, especially in the case of rare disease. It’s really difficult to convince a company to spend billions to develop a treatment that will only cure 1 in 100,000 people without letting them charge an arm and a leg, and giving them a very long exclusivity deal so they can continue to charge high prices. So much of that cost to develop is due to the dozens of other failed drugs and formulations they tried on their way to success.
I don’t have a solution for the problem, and I’m always a little suspicious of anyone who claims it’s easy to solve. I think the UK has a decent idea, the NHS basically decides if the cost of a drug will be covered by insurance by comparing the expected benefit and the current cost. If the ratio is too skewed, they refuse to cover the medication. In theory, this should be an incentive for a company to charge less. In practice, it leads to some companies choosing not to market in the UK.